المؤلفون: Karla L Loss, Carla Manterola, Alberto Farina, Osama E A Idris, Anna Stein, Pierina Danos, Elias M Morón, Carolina F de Sousa, Dina Maki, Antônio Felipe Raquelo-Menegassio, Rofida A A Mahmoud, Carolina Victor, Rocio Ortiz-Lopez, Sergio Gresse, Fabiano Ferreira Abrantes, Fatima Iqbal, Lorenzo Thompson, Joanna Jimenez-Pavón, Mariam W J Nashwan, Anthony Gutierrez, Jazmin Camacho-Vilchez, Matthias Diebold, Lygia Bonanato, Marianna A G Galvani, Daniella Braz Parente, Erica V Stelmaszewski, Maria V C P Da Silva, Juan P Polania

المصدر: Cardiology in the young. 30(3)

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Antineoplastic Agents, 030204 cardiovascular system & hematology, Placebo, Pericardial effusion, Heart Neoplasms, 03 medical and health sciences, Tuberous sclerosis, 0302 clinical medicine, Clinical Trials, Phase II as Topic, Double-Blind Method, Tuberous Sclerosis, Intensive care, medicine, Humans, Multicenter Studies as Topic, Everolimus, Prospective Studies, Adverse effect, Child, Randomized Controlled Trials as Topic, business.industry, General Medicine, medicine.disease, Rhabdomyoma, Tumor Burden, Clinical trial, Treatment Outcome, Heart failure, Pediatrics, Perinatology and Child Health, Quality of Life, Cardiology and Cardiovascular Medicine, business, 030217 neurology & neurosurgery, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab8b4b9fae72d234d0983fcdaa2d300
https://pubmed.ncbi.nlm.nih.gov/31983379